Active oxygen species play a role in mediating platelet aggregation and cyclic flow variations in severely stenosed and endothelium-injured coronary arteries.
- 1 November 1993
- journal article
- abstracts
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 73 (5) , 952-967
- https://doi.org/10.1161/01.res.73.5.952
Abstract
A canine model with cyclic flow variations (CFVs) in stenosed and endothelium-injured coronary arteries was used to examine the role of active oxygen species in platelet aggregation in vivo. We studied 90 anesthetized dogs in which the pericardial cavity was opened and the heart was exposed. The velocity of blood flow in the left anterior descending coronary artery (LAD) was monitored by a pulsed Doppler flow probe. In 67 dogs, the LADs were stenosed by applying external constrictors at the site where the endothelium was mechanically injured. CFVs developed in all 67 dogs. Treatment with the antioxidants recombinant human copper-zinc superoxide dismutase (r-h-CuZnSOD), recombinant human manganese superoxide dismutase (r-h-MnSOD), and catalase eliminated platelet aggregation-associated coronary CFVs in 63%, 62%, and 64% of animals, respectively. Intravenous infusion of epinephrine restored CFVs in most dogs. Ketanserin, a serotonin (5-hydroxytryptamine2) receptor antagonist, abolished epinephrine-restored CFVs and eliminated CFVs in dogs in which CFVs had not been eliminated by free radical scavengers. In an additional 23 dogs, the LADs were stenosed but not mechanically injured. For control studies, saline was infused into the LADs of 5 dogs. Xanthine/xanthine oxidase was infused into the LADs of 8 dogs and induced CFVs in 4. Hydrogen peroxide was infused into the other 10 dogs and induced CFVs in 9. Histological analysis of the coronary artery revealed that the intima was significantly injured by the infusion. In ex vivo platelet aggregation studies, the in vivo treatment with r-h-CuZnSOD, r-h-MnSOD, and catalase significantly inhibited platelet aggregation induced by platelet-activating factor. Thus, active oxygen species are involved in mediating platelet aggregation and cyclic flow variations in stenosed and endothelium-injured canine coronary arteries in vivo.Keywords
This publication has 31 references indexed in Scilit:
- Coronary atherosclerosis: Current therapeutic approaches and future trendsLife Sciences, 1991
- Intraglomerular platelet aggregation and experimental glomerulonephritisKidney International, 1990
- The role of antiplatelet agents in modifying the extent of restenosis following percutaneous transluminal coronary angioplastyAmerican Heart Journal, 1990
- Percutaneous Transluminal Coronary Angioplasty in 1985–1986 and 1977–1981New England Journal of Medicine, 1988
- Neutrophil-derived, oxygen free radical-mediated cardiovascular dysfunctionJournal of Molecular and Cellular Cardiology, 1984
- Effects of the selective thromboxane synthetase inhibitor dazoxiben on variations in cyclic blood flow in stenosed canine coronary arteries.Circulation, 1984
- A radioimmunoassay for manganese containing superoxide dismutaseFEBS Letters, 1980
- A radioimmunoassay for copper containing superoxide dismutaseBiochemical and Biophysical Research Communications, 1979
- Myeloperoxidase-Mediated Platelet Release ReactionJournal of Clinical Investigation, 1979
- Leukocyte-platelet interaction. Release of hydrogen peroxide by granulocytes as a modulator of platelet reactions.Journal of Clinical Investigation, 1976